-
CMS Bundling Ruling Neutral for DaVita, Says Piper Jaffray (DVA)
Tuesday, July 27, 2010 - 10:19amPiper Jaffray analysts Mark Arnold and Bradley Fisher weighed in on the CMS' ruling for bundled dialysis services. The analysts said, "In total, the only real change to the average estimated bundled payment is the exclusion of certain oral drugs until 2014. Pending further commentary from the...
Read More >> -
Piper Jaffray Downgrades PetMed Express to Underweight (PETS)
Tuesday, July 20, 2010 - 7:35amPetMed Express (NASDAQ: PETS) reported disappointing earnings yesterday, and Piper Jaffray downgraded the company as a result. Piper analysts Mark Arnold and Bradley Fisher downgraded PetMed Express to Underweight, and lowered its price target by $5 to $14.00. The analysts said, "While some may...
Read More >> -
PetMed Express (NASDAQ: PETS) Downgraded to Neutral
Thursday, March 18, 2010 - 9:07amAnalysts at Piper Jaffray downgraded PetMed Express (NASDAQ: PETS) from Overweight to Neutral. The analysts explain, “We are downgrading shares of PETS from Overweight to Neutral this morning based strictly on valuation, as the stock has surged through our $21 price target this week and is up over...
Read More >>
